韩国做爰无遮A片床戏,第一财经电视直播,女人18毛片水真多,老头猛吸女大学奶头A片,借种灭门案完整观看国语

Regenerative Engineering And Translational Medicine
收藏雜(za)志
  • 數(shu)據庫(ku)收錄(lu)SCIE
  • 年發文(wen)量38

Regenerative Engineering And Translational Medicine

期刊中文名:再生工(gong)程與(yu)轉化醫學ISSN:2364-4133E-ISSN:2364-4141

該雜志國際(ji)簡稱:REGEN ENG TRANSL MED,是由出(chu)版(ban)商Springer Nature出(chu)版(ban)的(de)(de)一本致(zhi)力于發(fa)布(bu)--研究(jiu)新(xin)成(cheng)果的(de)(de)的(de)(de)專業(ye)學(xue)術期刊(kan)。主要(yao)(yao)發(fa)表(biao)刊(kan)登有(you)創見的(de)(de)學(xue)術論文文章、行業(ye)最(zui)新(xin)科研成(cheng)果,扼要(yao)(yao)報道階段性研究(jiu)成(cheng)果和重要(yao)(yao)研究(jiu)工作的(de)(de)最(zui)新(xin)進(jin)(jin)展(zhan),選載對學(xue)科發(fa)展(zhan)起指導(dao)作用的(de)(de)綜(zong)述與專論,促進(jin)(jin)學(xue)術發(fa)展(zhan),為廣大讀(du)者服務。該刊(kan)是一本國際(ji)優(you)秀雜志,在(zai)國際(ji)上有(you)很高的(de)(de)學(xue)術影響力。

基本信息:
期刊簡稱(cheng):REGEN ENG TRANSL MED
是否(fou)OA:未開放
是否預警(jing):
Gold OA文章占比:13.64%
出版信息:
出版周(zhou)期(qi):4 issues per year
出(chu)版語言(yan):English
出(chu)版商:Springer Nature
評價信息:
JCR分(fen)區:Q3
影響因子(zi):2.2
CiteScore:4.9
雜(za)志介紹 JCR分區 CiteScore 投稿經驗

雜志介紹

Regenerative Engineering And Translational Medicine雜志介紹

《Regenerative Engineering And Translational Medicine》是一(yi)本(ben)以(yi)English為主的(de)(de)(de)未(wei)開放獲取國(guo)際(ji)優(you)秀期(qi)刊(kan),中文名稱再生工程(cheng)與轉化(hua)醫學,本(ben)刊(kan)主要出(chu)版(ban)、報道領(ling)(ling)域(yu)的(de)(de)(de)研究動態(tai)以(yi)及在該(gai)領(ling)(ling)域(yu)取得的(de)(de)(de)各方面的(de)(de)(de)經驗和(he)(he)科研成果,介紹(shao)該(gai)領(ling)(ling)域(yu)有關(guan)本(ben)專(zhuan)業的(de)(de)(de)最新進(jin)展,探討(tao)行(xing)(xing)業發展的(de)(de)(de)思(si)路和(he)(he)方法,以(yi)促進(jin)學術信息交流,提高(gao)行(xing)(xing)業發展。該(gai)刊(kan)已被國(guo)際(ji)權威數(shu)據庫SCIE收錄,為該(gai)領(ling)(ling)域(yu)相(xiang)關(guan)學科的(de)(de)(de)發展起到了良(liang)好(hao)的(de)(de)(de)推動作用,也得到了本(ben)專(zhuan)業人員的(de)(de)(de)廣泛認可。該(gai)刊(kan)最新影響因子為2.2,最新CiteScore 指數(shu)為4.9。

英文介紹

Regenerative Engineering And Translational Medicine雜志英文介紹

regenerative Engineering Is An International Journal Covering Convergence Of The Disciplines Of Tissue Engineering, Advanced Materials Science, Stem Cell Research, The Physical Sciences, And Areas Of Developmental Biology. This Convergence Brings Exciting Opportunities To Translate Bench-top Research Into Bedside Methods, Allowing The Possibility Of Moving Beyond Maintaining Or Repairing Tissues To Regenerating Them. The Journal Encourages Both Top-down Engineering Approaches And Bottom-up Strategies Integrating Materials Science With Stem Cell Research And Developmental Biology. Convergence Papers On Instructive Biomaterials, Stimuli-responsive Biomaterials, Micro- And Nano-patterning For Regenerative Engineering, Elastomeric Biomaterials, Hydrogels For Tissue Engineering, And Rapid Prototyping And Bioprinting Approaches Are Particularly Welcome. 

The Journal Provides A Premier, Single-blind peer-reviewed Forum For The Publication Of Original Papers, Authoritative Reviews, Rapid Communications, News And Views, And Opinion Papers Addressing The Most Important Issues And Efforts Toward Successfully Regenerating Complex Human Tissues And Organs. All Research Articles Feature A Lay Abstract Highlighting The Relevance And Future Impact For Patients, Government And Other Health Officials, And Members Of The General Public. Bridging The Gap Between The Lab And The Clinic, The Journal Also Serves As A Dedicated Platform For Showcasing Translational Research That Brings Basic Scientific Research And Discoveries Into Clinical Methods And Therapies, Contributing To The Improvement Of Human Health Care.topics Covered In Regenerative Engineering And Translational Medicine include:advanced Materials Science For Regenerative And Biomedical Applicationsstem Cells For Tissue Regenerationdrug Delivery For Tissue Regenerationnanomaterials And Nanobiotechnology For Tissue Regenerationstudies Combining Tissue Engineering/regeneration With Developmental Biologyconvergence Research In Pre-clinical And Clinical Phases

JCR分區(2023-2024年最新版)

Regenerative Engineering And Translational Medicine雜志 JCR分區信息

按JIF指標(biao)學科分區(qu)
學科:ENGINEERING, BIOMEDICAL
收錄子集:ESCI
分區:Q3
排名:82 / 122
百分位:

33.2%

按JCI指標學科分區
學科:ENGINEERING, BIOMEDICAL
收錄子集:ESCI
分區:Q4
排名:97 / 122
百分位:

20.9%

JCR分區:JCR分(fen)區(qu)(qu)來自科(ke)(ke)睿唯(wei)安(an)公司(si),JCR是(shi)一個獨特的(de)多學(xue)科(ke)(ke)期(qi)刊(kan)評價工具(ju),為唯(wei)一提供基于(yu)引(yin)文數據(ju)的(de)統(tong)計信息的(de)期(qi)刊(kan)評價資源。每年(nian)發布的(de)JCR分(fen)區(qu)(qu),設置了254個具(ju)體(ti)學(xue)科(ke)(ke)。JCR分(fen)區(qu)(qu)根據(ju)每個學(xue)科(ke)(ke)分(fen)類按(an)照期(qi)刊(kan)當年(nian)的(de)影響因子高低將期(qi)刊(kan)平均分(fen)為4個區(qu)(qu),分(fen)別為Q1、Q2、Q3和Q4,各(ge)占25%。JCR分(fen)區(qu)(qu)中期(qi)刊(kan)的(de)數量是(shi)均勻分(fen)為四個部分(fen)的(de)。

CiteScore 評價數據(2024年最新版)

Regenerative Engineering And Translational Medicine雜志CiteScore 評價數據

  • CiteScore 值:4.9
  • SJR:0.487
  • SNIP:0.513
學科類別 分區 排名 百分位
大類:Medicine 小類:Medicine (miscellaneous) Q2 113 / 398

71%

大類:Medicine 小類:Biomedical Engineering Q2 135 / 303

55%

大類:Medicine 小類:Biomaterials Q3 73 / 137

47%

大類:Medicine 小類:Cell Biology Q3 195 / 285

31%

歷年影響因子和期刊自引率

投稿經驗

Regenerative Engineering And Translational Medicine雜志投稿經驗

該(gai)雜(za)(za)(za)志(zhi)(zhi)是一本國際優(you)(you)秀雜(za)(za)(za)志(zhi)(zhi),在國際上有較高的學術(shu)影響(xiang)力,行(xing)業關注度很高,已被國際權威數據庫SCIE收錄,該(gai)雜(za)(za)(za)志(zhi)(zhi)在綜合專(zhuan)業領域(yu)專(zhuan)業度認可(ke)很高,對稿(gao)(gao)件(jian)內容的創新性和學術(shu)性要求很高,作為一本國際優(you)(you)秀雜(za)(za)(za)志(zhi)(zhi),一般投(tou)稿(gao)(gao)過審(shen)時間都較長,投(tou)稿(gao)(gao)過審(shen)時間平均 ,如果想(xiang)投(tou)稿(gao)(gao)該(gai)刊(kan)要做好時間安(an)排。版面費不(bu)祥。該(gai)雜(za)(za)(za)志(zhi)(zhi)近兩年未被列(lie)入預警名單,建議(yi)您投(tou)稿(gao)(gao)。如您想(xiang)了(le)解更(geng)多投(tou)稿(gao)(gao)政策(ce)及投(tou)稿(gao)(gao)方案,請咨詢客(ke)服。

免責聲明

若用(yong)戶需要出版服(fu)務,請聯(lian)系(xi)出版商。